Amgen Approach to Value-Based Partnerships

  • November 16, 2017
  • 2:00 PM – 3:00 PM ET
  • Online
about

Given the rising cost of health care, the need for quality care, and the need to improve patient experience, partnerships between manufacturers, payers, and providers will play a key role in advancing medical care in the United States.

This webinar will explore:

  • The definition of value based partnerships
  • The various stakeholders and their potential interest in value based partnerships
  • The types of value based partnerships
  • The benefits and challenges of value based partnerships

Attendees will learn:

  • What defines a value based partnership versus a sponsorship or service agreement;
  • The benefits of setting up value based partnerships;
  • The challenges in setting up value based partnerships, including legal, organizational, and regulatory; and
  • How organizations are contributing resources to execute value based partnerships.

Who should attend: Health Care Professionals, Payers, Health System Administrators


Speakers:


Victoria Atencio
Director, Value & Access
US Value Based Partnerships

Victoria Atencio has 20 years of experience in the pharmaceutical and biotechnology industry.  Victoria has focused her career on brand marketing, launch preparedness, and access/reimbursement. Currently, Victoria is a marketing director at Amgen and is responsible for population health and value based partnerships.  Victoria earned her BA from Smith College and her MBA from the Wharton School with a major in health care.


Stephanie Jorden
Director
Global Value-Based Partnerships

Stephanie runs strategy and operations for Amgen’s Global Value-Based Partnership group, a newly established organization who is focused on transforming Amgen from a transactional supplier of medicines into a collaborative partner within the healthcare system.  As a founding member of this organization, Stephanie has helped design and resource a team that is dedicated to moving the needle on value-based healthcare.  A finance and process excellence professional by training, Stephanie has held roles at Amgen in Corporate Strategy, Business Performance, and Transformation over the past four years.

Prior to Amgen, Stephanie spent 7+ years at General Electric, first in their rotational Financial Management Program at GE Capital, followed by GE’s elite Corporate Audit Staff, an organization providing specialized training designed to build leadership skills that expand across hemispheres and cultures.  Stephanie also spent 2+ years at GE Aviation in Singapore, owning the risk management and pricing of service agreements for commercial airlines operating in Asia and partnering with the commercial team to develop unique and comprehensive customer solutions.  GE provided extensive global experience, enabling Stephanie to work in Asia, Africa, Europe, and the US.

Stephanie received MBAs from UCLA Anderson and the National University of Singapore, and a Bachelor of Science in Finance from Syracuse University.  She currently sits on advisory boards at both UCLA Anderson and Syracuse Whitman Schools of Management.